Close Icon

Carlyle and Healthcare Venture Funds Invest in Saama.

As part of a growth investment of up to $430M, Carlyle and venture funds from Merck, Pfizer, Amgen, McKesson and others have embraced AI technologies for accelerating the delivery of safe and effective medical treatments.

Do More with Data-Driven Drug Development.

State-of-the-art clintech from Saama is designed to streamline your workflows, automate time-consuming processes, and improve collaboration across clinical operations, medical review, data management, biostatistics, and pharmacovigilance.

Sponsors and CROs rely on Saama for data aggregation and artificial intelligence solutions that lead to better decision-making, eliminate delays, and significantly shrink drug development costs and timelines.

>

Saama's Intelligent Clinical Cloud Offering: Life Science Analytics Cloud (LSAC)

Accelerated Clinical Trials Icon

Accelerated
Clinical Trials

When all your clinical data is in one place and updated in real time, life’s much easier for your ClinOps and Medical Review teams.

Automated Data Management Icon

Automated
Data Quality

Data Managers have been underappreciated for too long. Eliminate manual work so they can pay attention to the data points that matter most.

Streamline Regulatory Submissions Icon

Streamline Regulatory Submissions

Pharmacovigilance teams can generate regulatory submissions in minutes, and actively monitor drug safety signals after drugs get approved.

Partners in Innovation: Saama Success Stories

Saama builds long-lasting relationships with the most respected pharmaceutical companies, nonprofit organizations, universities, and government agencies in the world, by delivering game-changing solutions that improve clinical trial outcomes.

Access Out-of-the-Box Features in 4 Weeks—Guaranteed.

Saama can put you on the fast track to clinical trial process innovation.

Terms & Conditions

By inquiring about Saama’s Database Lock in a Day, you agree to be contacted by Saama and to allow Saama to use, maintain, store, and protect your personal data in accordance with our Privacy Policy.

Eligibility details are for informational purposes only. Saama, in its sole discretion, will determine your eligibility based on the information you disclose as part of the intake process. If Saama determines that you are eligible to participate, you will be notified by separate email. Eligibility depends on certain criteria, such as the size of your company, the types of clinical trials you sponsor, and the number of patients in–and stages of–your current clinical trials.

By completing the request form, you represent that you have authority to proceed on behalf of your company. Should you agree to participate, you agree to reasonably cooperate with Saama in following the guidelines and procedures required for integrating, standardizing, and analyzing your data. Participation requires the use of our Smart Data Quality application, a technology-agnostic AI engine that sits on top of your current infrastructure. The application can be used immediately, and you’re only charged for the services you use based on a predetermined estimate.

Information you share with Saama during your participation may be anonymized and/or aggregated, and made available publicly in Saama marketing materials. This information may include: types of systems and processes involved, types of departments involved, and size and regional location of your company. Such information will never be directly associated with you, nor will you or your company be identifiable without express written permission.